17 of 21 appropriate candidates successfully completed inpatient mammograms; all except one were negative
THURSDAY, Jan. 28, 2021 (HealthDay News) — Performing targeted inpatient screening mammograms can improve breast cancer screening rates among Medicaid and dually eligible patients, according to a pilot study published in the January/February issue of the Annals of Family Medicine.
Andrew S. Hwang, M.D., M.P.H., from Massachusetts General Hospital in Boston, and colleagues performed targeted screening mammograms among Medicaid and dually eligible patients admitted to the General Medicine service at a large, urban, academic medical center between March 2019 and March 2020. Potential intervention candidates who were overdue for breast cancer screening and did not have an outpatient mammogram already scheduled were identified. Twenty-one patients were deemed appropriate candidates for screening mammograms before discharge.
The researchers found that 17 of the patients successfully completed inpatient mammograms and four were discharged before the mammogram could be coordinated. Patients who did and did not complete a screening mammogram had no difference in average hospital length of stay. All except one of the screening mammogram results were negative.
“We designed the study to reach the patients who face significant barriers to completing their mammograms in the outpatient setting,” Hwang said in a statement. “National and local data show that Medicaid and dual-eligible patients have low rates of breast cancer screening. This targeted strategy has the potential to reduce disparities in cancer screening rates by addressing patients’ acute medical needs and their preventive care needs simultaneously.”
Hospital Outcomes Better When Patients Treated by Female Physicians
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer
Dense Breast Notification Linked to Increase in Use of Supplemental Ultrasound
AI Better Assesses Heart Function From MRI Than Clinicians
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy